SCP Vitalife

SCP Vitalife Partners is a venture capital investment firm focused on life-sciences investments in Israel and the United States, investing in companies operating in pharmaceuticals, medical devices, diagnostics, digital health, and adjacent healthcare / biotechnology themes. The firm is the product of the combined Strategic Capital Partners (SCP) and Vitalife Partners life-sciences-focused investment activities, with transatlantic U.S.-Israel reach and operations across both biotechnology hubs. The firm operates as a sector-specialist Israel-U.S. biotech investor alongside other prominent Israel-U.S. healthcare VCs including OrbiMed Israel Partners, Pontifax, aMoon Partners, and Peregrine Ventures. Detailed aggregate current-fund AUM, fund-vintage disclosures, named general partners, Israel Securities Authority (ISA) and SEC registration status, and comprehensive portfolio-company disclosures are partially documented in mainstream financial-industry databases for this specific URL. The row should be noted as Active with moderate public disclosure.